跳至主要内容
临床试验/JPRN-UMIN000004300
JPRN-UMIN000004300招募中4 期

Anti-Hypertensive treatment of Nephrosclerosis in Elderly - Anti-Hypertensive treatment of Nephrosclerosis in Elderly

Department of Nephrology, University of Tsukuba.0 个研究点目标入组 100 人开始时间: 2010年10月1日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Hypertensive crisis 2. Hyperkalemia (serum potassium conc.>5.5mM) 3. renal failure (eGFR<30ml/min/1.73m2) 4. bilateral renal artery stenosis 5. newly onset of stroke (within 6 months just before entry) 6. severe congestive heart failure (more than NYHA class III) 7. liver dysfunction (AST/ALT concentration is 5 fold higher than normal range) 8. newly onset of acute myocardial infarction. 9. Malignancy 10. Patients who had severe adverse reactions by Ca channel blockers of RAS inhibitors. 11. Patients who are prescribed immunosuppressant or glucocorticoids. 12. Patients who are prescribed NSAIDs for long time (more than 2 weeks). 13. Patients whose doctors determined as inadequate for the study.

研究者

发起方
Department of Nephrology, University of Tsukuba.

相似试验